Publications by authors named "Tracy Stites"

Claim this Profile
E
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
Patricia Pozo-Rosich, David Dolezil, Koen Paemeleire, Adam Stepien, Philipp Stude, Tracy Stites

JAMA Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
Uwe Reuter, Peter J Goadsby, Michel D Ferrari, Gabriel Paiva Da Silva Lima, Subhayan Mondal, Tracy Stites

Neurology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study.
Michel Dominique Ferrari, Uwe Reuter, Peter J Goadsby, Gabriel Paiva da Silva Lima, Subhayan Mondal, Tracy Stites

J Neurol Neurosurg Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIG study.
Douglas L Arnold, Brenda Banwell, Amit Bar-Or, Angelo Ghezzi, Benjamin M Greenberg, Tracy E Stites

J Neurol Neurosurg Psychiatry· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIG.
Kumaran Deiva, Peter Huppke, Brenda Banwell, Tanuja Chitnis, Jutta Gärtner, Tracy Stites

J Neurol Neurosurg Psychiatry· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
Tanuja Chitnis, Douglas L Arnold, Brenda Banwell, Wolfgang Brück, Angelo Ghezzi, Tracy Stites

N Engl J Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Jeffrey A Cohen, Bhupendra Khatri, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Tracy Stites

J Neurol Neurosurg Psychiatry· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Jens Kuhle, Giulio Disanto, Johannes Lorscheider, Tracy Stites, Yu Chen

Neurology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Peter A Calabresi, Ernst-Wilhelm Radue, Douglas Goodin, Douglas Jeffery, Kottil W Rammohan, Tracy Stites

Lancet Neurol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.
Bhupendra Khatri, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Ludwig Kappos, Tracy Stites

Lancet Neurol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Jeffrey A Cohen, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Bhupendra O Khatri, Tracy Stites

N Engl J Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice.
Tracy Stites, David Storms, Kathryn Bauerly, James Mah, Calliandra Harris

J Nutr· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets.
Francene Steinberg, Tracy E Stites, Peter Anderson, David Storms, Ivan Chan

Exp Biol Med (Maywood)· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis